Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions — VISION Network, September 2023–February 2024

Link-Gelles, R., Rowley, E. A. K., DeSilva, M. B., Dascomb, K., Irving, S. A., Klein, N. P., Grannis, S. J., Ong, T. C., Weber, Z. A., Fleming-Dutra, K. E., McEvoy, C. E., Akinsete, O., Bride, D., Sheffield, T., Naleway, A. L., Zerbo, O., Fireman, B., Hansen, J., Goddard, K., … Payne, A. B. (2024). Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions — VISION Network, September 2023–February 2024. MMWR. Morbidity and Mortality Weekly Report, 73(12), 271–276. https://doi.org/10.15585/mmwr.mm7312a5
Authors:
Ruth Link-Gelles
Elizabeth A.K. Rowley
Malini B. DeSilva
Kristin Dascomb
Stephanie A. Irving
Nicola P. Klein
Shaun J. Grannis
Toan C. Ong
Zachary A. Weber
Katherine E. Fleming-Dutra
Charlene E. McEvoy
Omobosola Akinsete
Daniel Bride
Tamara Sheffield
Allison L. Naleway
Ousseny Zerbo
Bruce Fireman
John Hansen
Kristin Goddard
Brian E. Dixon
Colin Rogerson
William F. Fadel
Thomas Duszynski
Suchitra Rao
Michelle A. Barron
Sarah E. Reese
Sarah W. Ball
Margaret M. Dunne
Karthik Natarajan
Erica Okwuazi
Ami B. Shah
Ryan Wiegand
Mark W. Tenforde
Amanda B. Payne
Affiliated Authors:
Karthik Natarajan
Publication Type:
Article
Unique ID:
10.15585/mmwr.mm7312a5
PMID:
Publication Date:
Data Source:
Scopus

Record Created: